Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2

This study investigated the performance of a rapid point-of-care antibody test, the BioMedomics COVID-19 IgM/IgG Rapid Test, in comparison with a high-quality, validated, laboratory-based platform, the Roche Elecsys Anti-SARS-CoV-2 assay. Serological testing was conducted on 709 individuals. Concord...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, Peter V., El Kahlout, Reham Awni, Dargham, Soha R., Chemaitelly, Hiam, Kacem, Mohamed Ali Ben Hadj, Al-Mawlawi, Naema Hassan Abdulla, Gilliani, Imtiaz, Younes, Nourah, Al Kanaani, Zaina, Al Khal, Abdullatif, Al Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Rahim, Hanan F. Abdul, Nasrallah, Gheyath K., Yassine, Hadi M., Al Kuwari, Mohamed G., Al Romaihi, Hamad Eid, Tang, Patrick, Bertollini, Roberto, Al-Thani, Mohamed H., Abu-Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803198/
https://www.ncbi.nlm.nih.gov/pubmed/35100295
http://dx.doi.org/10.1371/journal.pone.0262897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803198/
https://www.ncbi.nlm.nih.gov/pubmed/35100295
http://dx.doi.org/10.1371/journal.pone.0262897

Ejemplares similares